Global Continuous Glucose Monitoring Market, By Component (Sensors, Receivers and Transmitters, Integrated Insulin Pumps and External Monitors) By Age Group (Below 15, 16 To 40, 41 To 60, Above 60), By End-Users (Hospitals, Clinics and Diagnostic Centers, Home Care and Others) – Global Industry Insights, Trends and Forecast, 2017 - 2025

Created On: Jun-2018
Report ID: IR83
Format: PDF

Global Continuous Glucose Monitoring Market: Introduction

Continuous glucose monitoring (CGM) is an effective way to monitor the sugar levels to understand the varying blood sugar level during the day and to understand the state of glycemic excursions in a patient. CGM systems provide actual glucose information in the range of every five minutes offering up to nearly 288 readings in a period of 24-hours, and also helps by providing insights to monitor and control diabetes. These systems are helpful for patients who have high blood sugar levels during odd times of the day and are not detected by regular tests such as fasting blood sugar or blood sugar test after food intake. Hence, the use of CGM systems provides essential insights, thereby allowing to modify the treatment of diabetes among patients according to the requirement. Global continuous glucose monitoring market is projected to grow over the projected period, owing to a significant growth in the prevalence of diabetes among the population, coupled with high geriatric population across the globe.

Market Dynamics

One of the major factors driving the growth of continuous glucose monitoring market is the increasing diabetic population across the globe. According to the International Diabetes Federation, it is estimated that around 425.0 million people are suffering from diabetes globally, among which nearly 82.0 million people were from the South East Asia region. Furthermore, growing geriatric population, along with rising obesity cases among the population is further leading to the growth of diabetic population worldwide, which will, in turn, improve the demand for global continuous glucose monitoring market over the projected period.

However, these monitoring devices might get restricted towards growth by stringent norms by the government bodies. For instance, there are some ongoing approval issues from U.S. FDA on these monitoring devices. Moreover, these monitoring devices are also facing frequent technology failures which would restrain the growth of continuous glucose monitoring market.

By End-Users

Global continuous glucose monitoring market for home care end-user segment is anticipated to hold the prime share over the anticipated period, primarily attributed to the easy use and the portability of these devices for self-monitoring at the patients’ home. Further, the rise in geriatric population across the globe is another factor contributing to the increasing demand for the continuous glucose monitoring devices. Increasing demand as per the requirement among such patients to continuously monitor their glucose levels at home is owing to the product’s ease in accessibility, which is further fueling the continuous glucose monitoring market over the projected period. According to estimates by the United Nations, nearly 962.0 million people are accounted over the age of 60 years, out of the global population, and in among them, 13% are geriatric population.

Regional Outlook

In terms of geographic segmentation, North America continuous glucose monitoring market is expected to hold the majority of the global market in 2017 owing to the presence of high product awareness among the population, along with growing diabetic population, and adoption of new technologies in the healthcare sector. Moreover, high diabetic diagnostic spending in this region will further enhance the demand for continuous glucose monitoring systems. According to the American Diabetes Association, it was estimated that 30.3 million Americans had diabetes in 2015 while it is estimated that around 1.5 Americans are diagnosed with diabetes every year.

APAC continuous glucose monitoring market is projected to be one of the fastest growing markets, owing to the high prevalence of diabetic population in the region. According to the International Diabetes Federation, in 2017 around 72.9 million of the Indian population and around 114.4 million of Chinese population had diabetes within the age group of 20-79 years and they are expected to reach 134.3 million and 119.8 million for India and China respectively by the end of 2045, which will increase the product demand, and improve the share of Asia Pacific continuous glucose monitoring market over the projected period.

Competitive Landscape

Technological advancements and product launches are key to the growth of the global continuous glucose monitoring market. For instance, in 2018, the FDA approved a new glucose monitoring system by Dexcom Inc, to check the blood sugar levels in people suffering from diabetes and can also be used along with insulin pumps.

Some key players in the global continuous glucose monitoring system market include Bayer A.G., Abbott Laboratories, Medtronic Plc, Johnson & Johnson Inc, Roche Holdings A.G., Sensionics Incorporated, Dexcom Inc, Mernarini Diagnostics S.R.L., Echo Therapuetics Inc., and Arkray USA Inc.

Our Research Approach Includes
  •  Market Outlining
  •  Framing discussion guide
  •  Data Validation
  • Data Analysis
  •  Re-Validation and Finalization of Data
  •  Report Insights and Publishing
Our Research Approach Includes
  •  Market Outlining
  •  Framing discussion guide
  •  Data Validation
  • Data Analysis
  •  Re-Validation and Finalization of Data
  •  Report Insights and Publishing
Reach Out to us